Kempen (Lux) Euro Credit Fund receives Morningstar Gold rating

Jeroen Siecker, Morningstar fund analyst, explained why the rating of the Kempen (Lux) Euro Credit Fund was upgraded from Silver to Gold: ‘The investment process of the Kempen (Lux) Euro Credit Fund is disciplined and has proven its value over the course of the years. The quality of the execution is very high: solid and risk-aware. Furthermore, the team behind the strategy is one of the most experienced teams in this sector. Under various market conditions, they are able to outperform, resulting in a strong long-term track record.’

Alain van der Heijden, head of the Credit team, stated: ‘We are extremely proud of the rating that Morningstar has bestowed on us. Nothing feels better than to receive recognition for an investment approach that works, an approach based on a well-considered, balanced investment process and intensive, close teamwork. As a team, we continuously anticipate market changes and developments within companies, following our investment philosophy in a disciplined manner. In the past eleven years, we have shown this to be a golden combination for the Kempen (Lux) Euro Credit fund.’

More on EURO CREDITS

Disclaimer
Kempen (Lux) Euro Credit Fund (the “Sub-Fund”) is a sub-fund of Kempen International Funds SICAV (the “Fund”), Fund”), domiciled in Luxembourg. This Fund is authorised in Luxembourg and is regulated by the Commission de Surveillance du Secteur Financier. Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as management company and regulated by The Netherlands Authority for the Financial Markets. Paying agent and representative in Switzerland is RBC Investor Services Bank S.A., Bleicherweg 7, CH-8027 Zurich, Switzerland. The Sub-Fund is registered with The Netherlands Authority for the Financial Markets under the license of the Fund. The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the

prospectus. These documents as well as annual report, semi-annual report and the articles of incorporation of the Fund are available free of charge at the registered office of the Fund located at 6H, route de Trèves, L-2633 Senningerberg, Luxembourg, at the offices of the representative in Switzerland and on the website of KCM (www.kempen.com/investmentfunds).

The Sub-Fund is registered for offering in a limited number of countries. The countries where the Sub-Fund is registered can be found on the website. The value of your investment may fluctuate. Past performance provides no guarantee for the future. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.

Subscribe

Please leave your email and we will send you our latest updates

Submitting your form

We have received your form

And we will get back to you soon.

Something went wrong

Please check your form for errors or try again later.

News & Knowledge

2020, 24 November

Dividend Update: All set for a style reversal?

It’s been a hard year for the value stocks that our dividend strategy typically invests in. Growth stocks have outperformed them this year (as they did in 2019), such that the valuation gap between the two has hit a historical high – growth stocks had become 230% more expensive than value firms by the end of September based on a composite of four valuation measures – P/E, P/CF, P/B and dividend yield.

2020, 24 November

Dividend update videos

Dividend is the backbone of our investment strategy. Providing a consistent return to shareholders urges companies to carefully manage their cashflows and balance sheet, and scrutinize their investment decisions. As the economy has come to an abrupt stop due to the COVID-19 crisis, regulators, companies and even investors are questioning whether it is prudent to return cash to shareholders when the outlook is filled with uncertainty. We agree, some companies will need all their available resources to weather the crisis. Many others however, are according to our opinion in good shape financially to see this through. Some companies are simply not impacted much directly.

2020, 17 November

Monthly Commentary

Following the election (and Trump’s legal shenanigans) in the US, and news of the Pfizer vaccine over the last week, anything I write about market events in October will have been superseded by the time this missive arrives. I want to take this opportunity instead to examine a wider issue that has been under examination recently, and one that is going to become quite topical for all governments as they begin to chart a way to recovery: do government deficits matter anymore?